Showing results (251-260 of 323) with videos related to
Sort By:
Pageof 33
The Journal of Cell Biology|September 2, 2022
Origin of cytoplasmic GDP-fucose determines its contribution to glycosylation reactionsPaulina Sosicka, Bobby G Ng, Lauren E Pepi, et al.Bioorganic & Medicinal Chemistry Letters|April 16, 2011
In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitorsTao Wang, Stephanos Ioannidis, Lynsie Almeida, et al.Bioorganic & Medicinal Chemistry Letters|February 8, 2011
3-amido-4-anilinocinnolines as a novel class of CSF-1R inhibitorDavid A Scott, Les A Dakin, David J Del Valle, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.Science (New York, N.Y.)|December 8, 2018
Functionally diverse type V CRISPR-Cas systemsWinston X Yan, Pratyusha Hunnewell, Lauren E Alfonse, et al.Bioorganic & Medicinal Chemistry Letters|August 13, 2008
Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancerDavid A Scott, Brian M Aquila, Geraldine A Bebernitz, et al.Advances in Therapy|December 9, 2021
Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled TrialsJuan Jose Garcia Sanchez, Juliette Thompson, David A Scott, et al.British Journal of Cancer|May 13, 2021
Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapyShegan Gao, Yiwen Liu, Xiaoxian Duan, et al.Nature|April 2, 2015
In vivo genome editing using Staphylococcus aureus Cas9F Ann Ran, Le Cong, Winston X Yan, et al.Nature Biotechnology|April 23, 2014
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cellsXuebing Wu, David A Scott, Andrea J Kriz, et al.Pageof 33